跳至主要内容
临床试验/IRCT20230505058093N1
IRCT20230505058093N1招募中3 期

The efficacy of Lavandula stoechas product on motor symptoms of patients with Parkinson's disease treated with levodopa : A double-blind clinical trial

Kerman University of Medical Sciences0 个研究点入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
干预性

入排标准

年龄范围
55 years 至 75 years(—)
性别
All

入选标准

  • Idiopathic Parkinson's disease
  • Age range of 55 to 75 years
  • The onset age of the disease is less than 5 years
  • Stages one to three of Parkinson's disease

排除标准

  • The lack of physical and mental ability to answer the questions
  • Alcohol and drug use
  • History of systemic physical diseases such as diabetes, heart and brain stroke, heart, respiratory and kidney failure and uncontrolled blood pressure
  • Occurrence of debilitating disease during treatment
  • Taking a new drug due to lack of response to levodopa treatment or intolerance to levodopa if the diagnosis is primary
  • Taking sedative drugs or drugs that interfere with lavender, such as antipsychotic drugs, monoamine oxidase inhibitors, benzodiazepines, tricyclic antidepressants, anticonvulsants, and barbiturates.

研究者

标识符

注册编号
IRCT20230505058093N1

日期

最近更新
(2年前)

监管与共享

是否有结果
否

相似试验